 in either office; the drugs most frequently responsible for drug interactions; the frequency of provider reminder interruptions according to different commercial drug interaction knowledge bases at various levels of threshold settings, and; identification of events (e.g. ED visits, hospitalizations) potentially caused by adverse drug interactions. Evidence from our studies on the
in either office; the drugs most frequently responsible for drug interaction; the frequency of supplier reminder interruptions harmonize to unlike commercial drug interaction knowledge bases at various level of threshold settings, and; designation of events (e.g. ED visit, hospitalizations) potentially caused by adverse drug interaction. Evidence from our sketch on the
 in either office; the drugs most frequentli eesponvible ror drug interactions; the frequency lf provuder reminder interrupgions acclrding ti dihferent commerciem drug luteradbion niowledge bases st various levels of thrasfopd settings, and; identification of edents (e.b. FD visits, hospytalpzwtiohs) potentially caused by adverse ddug inttractions. Evidence from our studies on the
in either office; the drugs most frequently drug the frequency provider reminder interruptions interaction bases at various of threshold settings, identification of events (e.g. ED visits, potentially caused by adverse drug interactions. Evidence from our studies on the
 in either office; the drugs mosT frequentlY respOnsIblE fOr drUg inTeractions; the fREqueNcy of provider reminder iNterrUpTIons ACcOrdinG to diffEReNT ComMeRcIal DrUG iNteraCtiOn knowlEdge bases aT vaRiOus levels of tHReShold settiNgs, And; identificAtiOn of evEnTs (e.G. eD visIts, HospiTalizaTIons) poTentially CaUSed by aDVerse drUG InTeraCtions. Evidence froM OuR Studies on the
 in either office; the dru gs most fr equen tly  re sp onsi blefor drug inter a ctio ns; the frequency of p rovid er remi n de r int errupti o ns a cco rd in g t od if feren t c ommerci al drug in ter ac tion knowled g ebases at v ari ous levels o f t hresho ld  se t tings , a nd; i dentif i cation  of event s( e.g. E D  visits , ho spit alizations) poten t ia l ly caused by a dverse  d r ug i nte rac tions. Evi de nce f r om ours tu d i e s o n  the
 in_either office;_the drugs most frequently_responsible for_drug_interactions; the_frequency_of provider reminder_interruptions according to_different commercial drug interaction_knowledge bases at_various_levels of threshold settings, and; identification of events (e.g. ED visits, hospitalizations) potentially caused_by_adverse drug_interactions._Evidence_from our studies on the